TSLP caused the release of CCL17 by tumor cells with recruitment of eosinophils that in turn induced proliferation and restricted tumor cell apoptosis through up-regulation of Ki-67 and Bcl-2, respectively (36) and of proangiogenic factors (37). The gene discussed is BCL2; the disease is neoplasm.